These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 14558698)

  • 1. Development of guidance modules by the PDA to extend and/or eliminate periodic validation: a proposal to PDA Scientific Advisory Board.
    Korczynski MS
    PDA J Pharm Sci Technol; 2003; 57(4):245-8. PubMed ID: 14558698
    [No Abstract]   [Full Text] [Related]  

  • 2. Oncologic Drugs Advisory Committee and conflicts of interest.
    Burki TK
    Lancet Oncol; 2016 Mar; 17(3):e95. PubMed ID: 26877161
    [No Abstract]   [Full Text] [Related]  

  • 3. Validation--how much is required?
    Sharp J
    PDA J Pharm Sci Technol; 1995; 49(3):111-8. PubMed ID: 7613988
    [No Abstract]   [Full Text] [Related]  

  • 4. Conflicts of Interest Among Patient and Consumer Representatives to U.S. Food and Drug Administration Drug Advisory Committees.
    Graham SS; Card DJ; Ahn S; Kim SY; Kessler MM; Olson MK
    Ann Intern Med; 2016 Oct; 165(8):606-607. PubMed ID: 27750309
    [No Abstract]   [Full Text] [Related]  

  • 5. Process map proposal for the validation of genomic biomarkers.
    Goodsaid F; Frueh F
    Pharmacogenomics; 2006 Jul; 7(5):773-82. PubMed ID: 16886901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does seating location impact voting behavior on Food and Drug Administration advisory committees?
    Broniatowski DA; Magee CL
    Am J Ther; 2013; 20(5):502-6. PubMed ID: 21642834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advisory committee; Pediatric Advisory Committee; establishment. Final Rule.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Aug; 69(147):46098-9. PubMed ID: 15287133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Ethical Challenges of Compassionate Use.
    Caplan AL; Ray A
    JAMA; 2016 Mar; 315(10):979-80. PubMed ID: 26868205
    [No Abstract]   [Full Text] [Related]  

  • 9. Advisory committees" critical to the FDA's product review process.
    Rados C
    FDA Consum; 2004; 38(1):17-9. PubMed ID: 15032199
    [No Abstract]   [Full Text] [Related]  

  • 10. Conflicts cause FDA to review advisory committees.
    Kondro W
    CMAJ; 2006 Jul; 175(1):23. PubMed ID: 16818900
    [No Abstract]   [Full Text] [Related]  

  • 11. One year after launch, drug safety board is dubbed a failure.
    Wadman M
    Nat Med; 2006 Mar; 12(3):258. PubMed ID: 16520751
    [No Abstract]   [Full Text] [Related]  

  • 12. PDA presentation at FDA Open Conference on Sterile Drug Manufacturing. Parenteral Drug Association.
    J Pharm Sci Technol; 1994; 48(1):4-6. PubMed ID: 8004417
    [No Abstract]   [Full Text] [Related]  

  • 13. Process analytical technology in the pharmaceutical industry: a toolkit for continuous improvement.
    Scott B; Wilcock A
    PDA J Pharm Sci Technol; 2006; 60(1):17-53. PubMed ID: 17089677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Process analytical technology and ASTM Committee E55.
    Watts DC; Afnan AM; Hussain AS
    Stand News; 2004 May; 32(5):25-7. PubMed ID: 15146856
    [No Abstract]   [Full Text] [Related]  

  • 15. A European perspective on regulation and technology.
    Sharp J
    PDA J Pharm Sci Technol; 1997; 51(3):104-10. PubMed ID: 9203822
    [No Abstract]   [Full Text] [Related]  

  • 16. New drug development in the United States from 1963 to 1990.
    DiMasi JA; Bryant NR; Lasagna L
    Clin Pharmacol Ther; 1991 Nov; 50(5 Pt 1):471-86. PubMed ID: 1934860
    [No Abstract]   [Full Text] [Related]  

  • 17. Improving the FDA's advisory committee process.
    Brass EP; Hiatt WR
    J Clin Pharmacol; 2012 Aug; 52(8):1277-83. PubMed ID: 21908879
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmaceutical quality assessment.
    Florence AT
    Int J Pharm; 2015 Aug; 491(1-2):1. PubMed ID: 26054801
    [No Abstract]   [Full Text] [Related]  

  • 19. The Food and Drug Administration advisory committees and panels: how they are applied to the drug regulatory process.
    Ciociola AA; Karlstadt RG; Pambianco DJ; Woods KL; Ehrenpreis ED;
    Am J Gastroenterol; 2014 Oct; 109(10):1508-12. PubMed ID: 25001252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. US advisory panellists on drug's safety had ties to manufacturers.
    Lenzer J; Epstein K
    BMJ; 2012 Jan; 344():e244. PubMed ID: 22234908
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.